The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Reassessment of Alzheimer's Drug Raises Hope–and Concerns

    Article obtained from Scientific American RSS Feed.

    Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price?

    — Read more on ScientificAmerican.com

    Dec, 06 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.